278 related articles for article (PubMed ID: 35648373)
1. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
Cole A; Ong VH; Denton CP
Clin Rev Allergy Immunol; 2023 Jun; 64(3):378-391. PubMed ID: 35648373
[TBL] [Abstract][Full Text] [Related]
2. Management review of scleroderma renal crisis: An update with practical pointers.
Foocharoen C; Tonsawan P; Pongkulkiat P; Anutrakulchai S; Mahakkanukrauh A; Suwannaroj S
Mod Rheumatol; 2023 Jan; 33(1):12-20. PubMed ID: 35349704
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.
Mouthon L; Bérezné A; Bussone G; Noël LH; Villiger PM; Guillevin L
Clin Rev Allergy Immunol; 2011 Apr; 40(2):84-91. PubMed ID: 20012923
[TBL] [Abstract][Full Text] [Related]
5. Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.
Ghossein C; Varga J; Fenves AZ
Curr Rheumatol Rep; 2016 Jan; 18(1):5. PubMed ID: 26711696
[TBL] [Abstract][Full Text] [Related]
6. [Scleroderma renal crisis].
Morović-Vergles J; Culo MI; Kaliterna DM
Reumatizam; 2010; 57(2):109-11. PubMed ID: 21875014
[TBL] [Abstract][Full Text] [Related]
7. Management of scleroderma renal crisis.
Nagaraja V
Curr Opin Rheumatol; 2019 May; 31(3):223-230. PubMed ID: 30870219
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma renal crisis.
Hudson M; Ghossein C; Steen V
Presse Med; 2021 Apr; 50(1):104063. PubMed ID: 33548376
[TBL] [Abstract][Full Text] [Related]
9. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
Farrukh L; Steen VD; Shapiro L; Mehta S
Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma renal crisis.
Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma renal crisis and renal involvement in systemic sclerosis.
Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
[TBL] [Abstract][Full Text] [Related]
12. Scleroderma renal crisis.
Bose N; Chiesa-Vottero A; Chatterjee S
Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.
Shimizu T; Iwamoto N; Okamoto M; Endo Y; Tsuji S; Takatani A; Igawa T; Umeda M; Fukui S; Sumiyoshi R; Kitamura M; Koga T; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Intern Med; 2019 Feb; 58(3):441-445. PubMed ID: 30146597
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
[TBL] [Abstract][Full Text] [Related]
15. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.
Shanmugam VK; Steen VD
Curr Opin Rheumatol; 2012 Nov; 24(6):669-76. PubMed ID: 22955019
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S;
Arthritis Res Ther; 2020 Mar; 22(1):59. PubMed ID: 32209135
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
[TBL] [Abstract][Full Text] [Related]
18. De novo normotensive scleroderma renal crisis six years after living-donor renal transplantation in a patient with overlapping systemic sclerosis/systemic lupus erythematosus syndrome: a case report.
Sanada H; Hara S; Horita M; Kawahara H; Yoshida M; Takahashi Y; Tsuge S; Zoshima T; Nishioka R; Ito K; Mizushima I; Matsushita T; Kawano M
BMC Nephrol; 2023 Dec; 24(1):355. PubMed ID: 38049714
[TBL] [Abstract][Full Text] [Related]
19. Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome.
Maritati F; Provenzano M; Lerario S; Corradetti V; Bini C; Busutti M; Grandinetti V; Cuna V; La Manna G; Comai G
Front Immunol; 2022; 13():878736. PubMed ID: 35958558
[TBL] [Abstract][Full Text] [Related]
20. [Scleroderma renal crisis].
Teixeira L; Servettaz A; Mehrenberger M; Noël LH; Guillevin L; Mouthon L
Presse Med; 2006 Dec; 35(12 Pt 2):1966-74. PubMed ID: 17159723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
